Our team covers consolidated expertise in the field of tissue engineering, bioengineering, regenerative medicine, informatics and entrepreneurship. The multidisciplinarity of the team allows to operate in the world of business and public administration at all levels.
By working with the world’s leading scientists in the field of tissue engineering, 3D tissue models and cellular biology, we aim to advance disease knowledge and drug testing by supporting with MIVO® technology, the next generation of effective in vitro 3D fluid-dynamic assays.
We enable the scientists to transform their testing concept in concrete programs, providing an in vitro human systemic platform that allows the use of clinically-relevant size tissue models and physiological fluidic environments.
Our MIVO-based technology provides quicker, more reliable and effective data, enabling R&D centers and pharma companies to accelerate the disease knowledge and preclinical drug testing
We continue to find new and innovative ways of collaborating with academic institutions, biotech and pharmaceutical companies.